NCT03643874 - Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions

Asthma

Interventions

DRUG

Halix albuterol 90 mcg

albuterol unit dose disposable DPI delivers 90 mcg of albuterol in the excipient lactose with each inhalation. Albuterol 90 mcg will be given on one of the treatment days in cumulative doses up to a total dose of 720 mcg

DRUG

albuterol HFA MDI 90 mcg

albuterol HFA MDI delivers 90 mcg of albuterol with each inhalation. Albuterol 90 mcg will be given on one of the treatment days in cumulative doses up to a total dose of 1440 mcg

Trial Locations (1)

27607

North Carolina Clinical Research, Raleigh